HORIZONS GLOBAL SOLUTIONS LLC

Lobbying for CAPTURA BIOPHARMA · Captura is developing an orally administered MCM for radionuclide contamination.

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · Arkansas · House · Senate · posted Apr 8, 2026

Lobbying activity 2

Defense

2026/2027 NDAA; FY2026/2027 Defense Appropriations

Disaster Planning/Emergencies

FY2026/2027 NDAA; FY2026/2027 Defense Appropriations

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.